| Dr Amanda Bree Salter, MD | |
|
28747 Woodward Ave, Berkley, MI 48072-0929 | |
| (248) 546-2133 | |
| (248) 546-6036 |
| Full Name | Dr Amanda Bree Salter |
|---|---|
| Gender | Female |
| Speciality | Ophthalmology |
| Experience | 14 Years |
| Location | 28747 Woodward Ave, Berkley, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255644902 | NPI | - | NPPES |
| 4406532 | Medicaid | MI | |
| 0M88850 | Other | MI | MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 4301096080 (Michigan) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Spiro And Shanbom Md Pc | 1254324296 | 2 |
News Archive
A little-known morphinelike drug is potentially more potent, longer lasting and less likely to cause constipation than standard morphine, a study led by a Loyola University Health System anesthesiologist has found.
Researchers at The University of Texas M. D. Anderson Cancer Center may have uncovered the reason why some people who are genetically predisposed to hormone-dependent cancers develop the disease as an adult, while others who are similarly susceptible don't.
LSU Health Sciences Center New Orleans has been awarded $12 million over five years by the National Institutes of Health to conduct research on diseases like prostate and stomach cancers, lymphoma and leukemia, dengue fever, tuberculosis, and herpes infections, as well as to support the development of academic research scientists.
Biologists at The University of Texas at Arlington have demonstrated that removing water molecules can deactivate caspase-3 enzymes, which opens new doors for treatment of autoimmune diseases like arthritis, which have been linked to overactive enzymes.
Patients with advanced kidney cancer, who received a targeted drug combined with a checkpoint-blocker immunotherapy agent had longer survival than patients treated with the standard targeted drug, said an investigator from Dana-Farber Cancer Institute, reporting results from a phase 3 clinical trial.
› Verified 1 days ago
| Entity Name | Spiro And Shanbom Md Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184845331 PECOS PAC ID: 1254324296 Enrollment ID: O20040406000853 |
News Archive
A little-known morphinelike drug is potentially more potent, longer lasting and less likely to cause constipation than standard morphine, a study led by a Loyola University Health System anesthesiologist has found.
Researchers at The University of Texas M. D. Anderson Cancer Center may have uncovered the reason why some people who are genetically predisposed to hormone-dependent cancers develop the disease as an adult, while others who are similarly susceptible don't.
LSU Health Sciences Center New Orleans has been awarded $12 million over five years by the National Institutes of Health to conduct research on diseases like prostate and stomach cancers, lymphoma and leukemia, dengue fever, tuberculosis, and herpes infections, as well as to support the development of academic research scientists.
Biologists at The University of Texas at Arlington have demonstrated that removing water molecules can deactivate caspase-3 enzymes, which opens new doors for treatment of autoimmune diseases like arthritis, which have been linked to overactive enzymes.
Patients with advanced kidney cancer, who received a targeted drug combined with a checkpoint-blocker immunotherapy agent had longer survival than patients treated with the standard targeted drug, said an investigator from Dana-Farber Cancer Institute, reporting results from a phase 3 clinical trial.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Amanda Bree Salter, MD 28747 Woodward Ave, Berkley, MI 48072-0929 Ph: (248) 546-2133 | Dr Amanda Bree Salter, MD 28747 Woodward Ave, Berkley, MI 48072-0929 Ph: (248) 546-2133 |
News Archive
A little-known morphinelike drug is potentially more potent, longer lasting and less likely to cause constipation than standard morphine, a study led by a Loyola University Health System anesthesiologist has found.
Researchers at The University of Texas M. D. Anderson Cancer Center may have uncovered the reason why some people who are genetically predisposed to hormone-dependent cancers develop the disease as an adult, while others who are similarly susceptible don't.
LSU Health Sciences Center New Orleans has been awarded $12 million over five years by the National Institutes of Health to conduct research on diseases like prostate and stomach cancers, lymphoma and leukemia, dengue fever, tuberculosis, and herpes infections, as well as to support the development of academic research scientists.
Biologists at The University of Texas at Arlington have demonstrated that removing water molecules can deactivate caspase-3 enzymes, which opens new doors for treatment of autoimmune diseases like arthritis, which have been linked to overactive enzymes.
Patients with advanced kidney cancer, who received a targeted drug combined with a checkpoint-blocker immunotherapy agent had longer survival than patients treated with the standard targeted drug, said an investigator from Dana-Farber Cancer Institute, reporting results from a phase 3 clinical trial.
› Verified 1 days ago
Dr. Jeffrey C Kalt, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 27901 Woodward Ave, Ste 200, Berkley, MI 48072 Phone: 248-398-2525 Fax: 248-398-9286 | |
Dr. Steven Adam Shanbom, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 28747 Woodward Ave, Berkley, MI 48072 Phone: 248-546-2133 Fax: 248-546-6036 |